DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $18,523,493,000 | -2.9% | 82,297 | -4.2% | 2.51% | -6.9% |
| Q4 2020 | $19,082,353,000 | +102070.3% | 85,902 | -1.0% | 2.70% | -7.2% |
| Q3 2020 | $18,677,000 | +8.3% | 86,734 | -11.1% | 2.91% | +3.7% |
| Q2 2020 | $17,247,000 | +25.4% | 97,532 | -1.9% | 2.80% | +12.4% |
| Q1 2020 | $13,757,000 | -12.8% | 99,392 | -3.3% | 2.49% | +7.3% |
| Q4 2019 | $15,777,000 | +4.3% | 102,798 | -1.9% | 2.32% | -1.7% |
| Q3 2019 | $15,129,000 | -1.4% | 104,747 | -2.5% | 2.36% | -3.2% |
| Q2 2019 | $15,350,000 | +7.2% | 107,405 | -0.9% | 2.44% | +2.4% |
| Q1 2019 | $14,314,000 | +21.8% | 108,422 | -4.9% | 2.38% | +9.6% |
| Q4 2018 | $11,750,000 | -8.6% | 113,949 | -3.7% | 2.18% | +3.8% |
| Q3 2018 | $12,860,000 | +8.0% | 118,347 | -1.9% | 2.10% | +8.6% |
| Q2 2018 | $11,908,000 | -0.2% | 120,672 | -1.0% | 1.93% | +0.9% |
| Q1 2018 | $11,932,000 | +4.4% | 121,871 | -1.0% | 1.91% | +10.0% |
| Q4 2017 | $11,426,000 | +8.7% | 123,093 | +0.4% | 1.74% | +5.0% |
| Q3 2017 | $10,515,000 | +0.7% | 122,581 | -0.9% | 1.66% | -1.8% |
| Q2 2017 | $10,442,000 | -3.0% | 123,731 | -1.7% | 1.69% | -3.0% |
| Q1 2017 | $10,764,000 | +6.1% | 125,850 | -3.5% | 1.74% | +2.7% |
| Q4 2016 | $10,148,000 | -1.6% | 130,366 | -0.9% | 1.70% | -0.3% |
| Q3 2016 | $10,312,000 | -22.8% | 131,545 | -0.5% | 1.70% | -23.7% |
| Q2 2016 | $13,355,000 | +7.0% | 132,226 | +0.5% | 2.23% | +9.2% |
| Q1 2016 | $12,483,000 | +4.9% | 131,591 | +2.7% | 2.04% | +6.7% |
| Q4 2015 | $11,904,000 | +9.8% | 128,161 | +0.7% | 1.91% | +5.7% |
| Q3 2015 | $10,842,000 | +2.4% | 127,237 | +2.9% | 1.81% | -0.4% |
| Q2 2015 | $10,583,000 | +2.8% | 123,645 | +1.9% | 1.82% | +7.3% |
| Q1 2015 | $10,298,000 | -2.2% | 121,295 | -1.3% | 1.69% | +2.8% |
| Q4 2014 | $10,532,000 | +11.0% | 122,882 | -1.6% | 1.65% | +11.5% |
| Q3 2014 | $9,489,000 | -2.8% | 124,884 | +0.7% | 1.48% | -0.1% |
| Q2 2014 | $9,763,000 | +1.7% | 124,012 | -3.1% | 1.48% | -7.4% |
| Q1 2014 | $9,601,000 | +2.6% | 128,011 | +5.6% | 1.60% | -2.9% |
| Q4 2013 | $9,362,000 | +10.6% | 121,272 | -0.7% | 1.64% | +2.5% |
| Q3 2013 | $8,467,000 | +7.8% | 122,147 | -1.6% | 1.60% | +3.3% |
| Q2 2013 | $7,858,000 | – | 124,140 | – | 1.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |